A Drug-drug Interaction Study of SH229 Tablets and Daclatasvir Dihydrochloride Tablets in Healthy Subjects
Status:
Completed
Trial end date:
2018-12-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the drug-drug interaction of SH229 tablets and
Daclatasvir dihydrochloride tablets. The study also evaluates the pharmacokinetics and
tolerability of co-administration of SH229 tablets and Daclatasvir dihydrochloride tablets in
healthy subjects. This study provides evidence for the designing of following clinical trial
protocols.